Altered ATRX/DAXX Expression and Telomere Length of Pancreatic Neuroendocrine Tumors in MEN-1 Syndrome

被引：0
|
作者：
de Wilde, R. F.
Heaphy, C. M.
Maitra, A.
Meeker, A. K.
Edil, B. H.
Wolfgang, C. L.
Ellison, T.
Schulick, R. D.
Molenaar, I. Q.
Valk, G. D.
Vriens, M. R.
Rinkes, I. H. M. Borel
Offerhaus, G. J. A.
Hruban, R. H.
Matsukuma, K. E.
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1843
引用
收藏
页码：442A / 442A
页数：1
相关论文
共 50 条
  • [31] Significance of ATRX/DAXX Expression and Alternative Lengthening of Telomeres in Insulinomas and Neuroendocrine Tumors of Small Intestine
    Neumayer, B.
    Normand, L.
    Hoffmeister, M.
    Friemel, J.
    Perren, A.
    Gress, T.
    Sipos, B.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 82 - 82
  • [32] ATRX/DAXX Status on Diagnostic FNA Informs Progression Free Survival Prognostication in Pancreatic Neuroendocrine Tumors
    Hedberg, Matthew
    Bernadt, Cory
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 366 - 366
  • [33] ATRX/DAXX Status on Diagnostic FNA Informs Progression Free Survival Prognostication in Pancreatic Neuroendocrine Tumors
    Hedberg, Matthew
    Bernadt, Cory
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 366 - 366
  • [34] Characterization of 142 Human Pancreatic Neuroendocrine Tumors: ATRX and DAXX Correlation with Clinical-Pathological Data
    Gaspar, T. B.
    Pinheiro, J.
    Canberk, S.
    Ince, U.
    Tokat, F.
    Lopes, J. M.
    Maximo, V
    Soares, P.
    Vinagre, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 9 - 9
  • [35] The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors
    Heaphy, Christopher M.
    Singhi, Aatur D.
    HUMAN PATHOLOGY, 2022, 129 : 11 - 20
  • [36] Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
    VandenBussche, Christopher J.
    Allison, Derek B.
    Graham, Mindy K.
    Charu, Vivek
    Lennon, Anne Marie
    Wolfgang, Christopher L.
    Hruban, Ralph H.
    Heaphy, Christopher M.
    CANCER CYTOPATHOLOGY, 2017, 125 (07) : 544 - 551
  • [37] The MEN-1 gene product is overexpressed in neuroendocrine tumors.
    Groetzinger, C
    Hessenius, C
    Wiedenmann, B
    GASTROENTEROLOGY, 2000, 118 (04) : A46 - A46
  • [38] Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region
    Casar-Borota, Olivera
    Botling, Johan
    Granberg, Dan
    Stigare, Jerker
    Wikstrom, Johan
    Boldt, Henning Bunsow
    Kristensen, Bjarne Winther
    Ponten, Fredrik
    Trouillas, Jacqueline
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (09) : 1238 - 1246
  • [39] ATRX-DAXX Complex Expression Levels and Telomere Length in Normal Young and Elder Autopsy Human Brains
    Cavalcante, Stella G.
    Silva, Clarisse P. N.
    Sola, Paula R.
    Tanaka, Leonardo Y.
    Oba-Shinjo, Sueli M.
    Marie, Suely K. N.
    DNA AND CELL BIOLOGY, 2019, 38 (09) : 955 - 961
  • [40] Low Diagnostic Accuracy of Tumor Markers for the Annual Screening of Pancreatic Neuroendocrine Tumors in MEN-1 Patients
    De Laat, J.
    Weijmans, M.
    Hermus, A. D.
    Dekkers, O.
    De Herder, W.
    Van der Horst-Schrivers, A.
    Drent, M.
    Bisschop, P.
    Havekes, B.
    Valk, G.
    NEUROENDOCRINOLOGY, 2012, 96 : 25 - 25
12345